YOLFTbeta
Pyridam Farma Tbk

Pyridam Farma Tbk

PYFA · JK · Healthcare / Drug Manufacturers - Specialty & Generic

139.00IDR+10.00 (+7.75%)

Price History

Full chart

Market Stats

Previous Close129.00
Open130.00
Day Range127.00 – 152.00
52-Week Range158.00 – 665.00
Volume19.62M
Market Cap2.22T
P/E (TTM)0.00
Forward P/E0.00
EPS-29.54
Dividend Yield0.00%
Beta0.79
50-Day Avg229.58
200-Day Avg308.08

About

PT Pyridam Farma Tbk engages in the pharmaceutical business in Australia, Indonesia, Philippines, Singapore, and India. The company operates through two segments, Pharmaceutical Products, Esthetic and Toll Manufacturing Services; and Medical Equipment segments. It supplies medical instruments and equipment, including clinical waste, collection swab, collection tube, innerbox DCA, KF94 mask, parafilm, PCR - extraction kit and extractor machine, speciment bag, sterile container, PCR machine- Gentier 48, and tube stopper. The company also provides skin care and beauty products; medical support products; and other consumer health products in the form of syrups, tablets, and capsules; sterile and injection; and sanitizers and antiseptics. In addition, it offers antiseptic solutions, betadine antiseptic skin cleansers, Betadine Vaginal Douche, Cold defense nasal and throat sprays, feminine hygiene, Guardix SG, Mouthwash and Gargle, Salep antiseptic products. PT Pyridam Farma Tbk was founded in 1976 and is headquartered in Jakarta Selatan, Indonesia. PT Pyridam Farma Tbk operates as a subsidiary of Rejuve Global Investment Pte. Ltd.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Yan Gwan Lee
  • Employees2.46K
  • HeadquartersSinar Mas Land Plaza Sudirman, Jakarta Selatan, Indonesia, 12920, Indonesia
  • Websitehttps://www.pyfa.co.id

Leadership

  • Mr. Yan Gwan LeePresident Director · b. 1963
  • Mr. Yenfrino GunadiCFO & Director · b. 1987
  • Dr. Paulus Widjanarko BrotosaputroCOO, Head of Pharmacovigilance & President Commissioner · b. 1965
  • Ms. Sinta Lestari NingsihVP of Finance, Accounting & Tax and Director
  • Ms. Nadia Miranty VerdianaHead of Legal · b. 1991
  • Joshua SandjajaHRD Manager
  • Andrey SeptianaHead of OTC
  • Mr. Antes Eko PrasetioChief Commercial Officer & Director
  • Mr. Panji PamungkasHead of the Internal Audit Unit
  • Ms. Herdiasti Anggitya DwisaniCorporate Secretary

Financials

Income Statement

Currency: IDR2001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue29.23B24.63B27.26B33.97B39.64B61.34B86.64B119.58B132.00B140.86B151.09B176.73B192.56B222.30B217.84B216.95B223.00B250.45B247.11B277.40B630.53B715.43B702.07B1.92T2.76T
Growth (%)--15.73%+10.67%+24.63%+16.69%+54.74%+41.26%+38.02%+10.39%+6.71%+7.27%+16.97%+8.95%+15.45%-2.01%-0.41%+2.79%+12.31%-1.33%+12.25%+127.30%+13.46%-1.87%+173.59%+43.71%
Cost of Revenue8.81B7.86B8.67B10.07B16.24B21.10B31.01B41.21B47.76B51.08B49.50B61.06B62.13B80.96B79.86B81.64B88.03B99.34B106.91B113.51B385.95B464.58B406.75B1.38T2.27T
Gross Profit----23.40B40.24B55.63B78.37B84.24B89.78B101.59B115.67B130.43B141.34B137.98B135.32B134.98B151.10B140.20B163.89B244.58B250.84B295.32B536.48B485.54B
Gross Margin----59.04%65.61%64.21%65.53%63.82%63.73%67.24%65.45%67.74%63.58%63.34%62.37%60.53%60.33%56.74%59.08%38.79%35.06%42.06%27.93%17.59%
Operating Expense----20.61B36.20B51.47B72.21B77.41B84.12B94.59B106.78B121.93B131.15B127.85B124.80B122.91B136.60B124.92B131.75B192.69B-95.01B293.44B643.36B649.64B
Operating Income8.67B1.49B1.85B2.42B2.79B4.04B4.16B6.16B6.83B5.66B7.00B8.90B8.50B10.19B10.14B10.52B12.06B14.51B15.28B32.14B51.90B345.86B1.88B-106.88B-164.10B
Operating Margin29.66%6.04%6.80%7.14%7.05%6.59%4.80%5.15%5.17%4.02%4.64%5.03%4.41%4.59%4.65%4.85%5.41%5.79%6.18%11.59%8.23%48.34%0.27%-5.56%-5.94%
EBITDA----2.80B4.38B4.56B5.45B7.39B6.98B8.08B16.06B14.72B13.70B12.72B19.70B20.68B21.82B22.72B41.28B83.74B421.42B60.70B-30.72B128.59B
EBITDA Margin----7.07%7.13%5.26%4.56%5.60%4.96%5.35%9.09%7.64%6.16%5.84%9.08%9.28%8.71%9.20%14.88%13.28%58.90%8.65%-1.60%4.66%
Net Income4.69B436.90M618.71M1.43B1.33B1.73B1.74B2.31B3.77B4.20B5.17B5.31B6.20B2.66B3.09B5.15B7.13B8.45B9.34B22.10B5.48B275.24B-85.22B-330.25B-379.67B
Net Income Margin16.06%1.77%2.27%4.21%3.35%2.82%2.01%1.93%2.86%2.98%3.42%3.00%3.22%1.20%1.42%2.37%3.20%3.37%3.78%7.97%0.87%38.47%-12.14%-17.19%-13.75%
R&D-----282.43M220.97M197.82M3.18B3.06B3.05B1.46B3.26B1.36B3.18B1.19B2.31B853.19M5.65B0573.44M11.28B17.77B17.62B21.54B
R&D as % of Total Revenue-----0.46%0.26%0.17%2.41%2.17%2.02%0.83%1.69%0.61%1.46%0.55%1.03%0.34%2.28%0.00%0.09%1.58%2.53%0.92%0.78%
Interest Expense0000858.23M1.55B1.93B1.81B1.96B1.34B991.43M1.88B3.22B5.99B5.59B3.47B2.47B3.21B2.79B2.56B41.93B86.91B86.50B225.98B325.90B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%2.17%2.53%2.23%1.51%1.49%0.95%0.66%1.07%1.67%2.69%2.56%1.60%1.11%1.28%1.13%0.92%6.65%12.15%12.32%11.76%11.81%

Balance Sheet

Currency: IDR2001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets76.67B69.75B68.27B70.43B76.55B83.13B95.16B98.66B99.94B100.59B118.03B135.85B175.12B172.56B159.95B167.06B159.56B187.06B190.79B228.58B806.22B1.52T1.52T5.81T6.77T
Total Liabilities16.14B9.66B7.56B8.29B13.08B17.93B28.21B29.40B26.91B23.36B35.64B48.14B81.22B75.46B58.73B61.55B50.71B68.13B66.06B70.94B639.12B1.08T1.16T4.77T5.79T
Total Equity60.52B60.09B60.71B62.14B63.47B65.20B66.94B69.25B73.03B77.23B82.40B87.71B93.90B97.10B101.22B105.51B108.86B118.93B124.73B157.63B167.10B442.13B356.83B1.04T766.99B
Cash1.23B831.26M569.47M334.99M722.90M348.69M2.11B1.98B3.13B3.85B4.52B5.34B7.57B2.93B3.73B1.37B379.65M1.95B5.29B9.64B47.73B136.58B89.97B351.86B101.79B
Total Debt----8.38B12.11B16.40B16.73B15.67B8.82B16.06B29.83B50.60B47.64B33.49B27.73B10.27B24.52B19.41B35.51B448.81B910.04B986.99B3.87T4.84T
Net Debt----7.66B11.76B14.29B14.75B12.54B4.97B11.54B24.49B43.03B44.71B29.76B26.36B9.89B22.57B14.12B25.88B401.08B773.46B897.02B3.52T4.74T

Cash Flow

Currency: IDR2001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow3.84B4.50B3.29B4.54B1.57B-2.73B3.83B736.54M5.02B9.54B1.69B-448.72M-5.86B1.47B15.70B2.83B2.84B1.76B17.61B1.11B39.59B275.24B-103.98B-141.04B-364.28B
Investing Cash Flow-----4.97B-1.37B-9.16B-1.88B-1.87B-2.73B-2.09B-12.52B-12.69B-3.15B-1.58B-1.88B-2.59B-19.51B-1.70B-6.58B-371.56B-243.00B-22.46B-2.56T49.18B
Financing Cash Flow4.08B---3.79B3.73B7.07B1.02B-2.00B-6.09B1.07B13.79B20.77B-2.96B-13.32B-7.53B-19.33B16.25B-12.56B9.62B370.07B326.36B79.84B2.95T66.27B
Capital Expenditure2.69B2.25B731.56M3.63B5.15B1.82B2.97B2.35B2.14B2.98B2.92B12.91B13.10B3.54B2.01B2.60B3.32B20.48B3.27B7.84B222.03B46.47B23.66B135.22B139.62B
Free Cash Flow-----3.57B-4.55B862.98M-1.62B2.88B6.56B-1.24B-13.36B-18.96B-2.07B13.69B231.36M-472.90M-18.72B14.34B-6.72B-182.45B228.77B-127.64B-276.26B-503.91B
Dividends Paid-868.40M------------1.55B1.55B1.55B2.14B2.14B0--031.63B0
FCF to OCF-----226.95%166.76%22.52%-219.41%57.39%68.76%-73.16%2977.15%323.75%-140.72%87.21%8.18%-16.63%-1065.18%81.43%-604.63%-460.88%83.12%122.75%195.87%138.33%
Dividend Paid to FCF--------------11.33%670.71%-328.13%-11.43%14.93%0.00%--0.00%-11.45%0.00%

Earnings

Report DateMar 31, 2004Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Mar 29, 2017Apr 26, 2017Aug 31, 2017Oct 27, 2017Mar 23, 2018Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Apr 29, 2019Jul 30, 2019Oct 29, 2019Mar 30, 2020May 6, 2020Jul 25, 2020Nov 2, 2020Dec 31, 2020Apr 16, 2021Aug 27, 2021Nov 30, 2021Dec 31, 2021Jun 2, 2022Aug 31, 2022Nov 30, 2022Dec 31, 2022Apr 6, 2023Aug 1, 2023
EPS Estimate----------------------------------------------------
EPS Actual2.25-1.978.662.50-1.49-0.015.151.221.082.472.900.031.357.303.13-2.17-0.174.172.110.42-1.184.431.773.170.364.312.45-0.157.283.743.060.134.857.753.52-0.235.918.268.162.4919.4811.1820.280.968.59-19.60-19.6012.25522.73-25.26-25.26-45.55
Surprise----------------------------------------------------
Timing-------------------------After-hoursPre-marketAfter-hoursPre-marketPre-market----Pre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-market-Pre-marketAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursPre-market

Key Statistics & Ratios

Market Cap2.22T
Enterprise Value7.89T
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.74
Price / Book3.84
EPS-29.54
Book Value60.89
Revenue (TTM)2.99T
Gross Profit (TTM)655.83B
EBITDA82.89B
Profit Margin-11.52%
Operating Margin-0.17%
Return on Equity-39.27%
Return on Assets-0.88%
Shares Outstanding11.24B
Shares Float3.36B
Beta0.79
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20191×
0.86May 31, 2019
20171×
0.62May 30, 2017
20021×
0.36Nov 5, 2002